Drug Addiction
Drug Addiction is a condition listed in the mental health category. The evidence summarized here considers cocaine craving and relapse among people being treated for CUD.
Explore Drug Addiction as a condition listed in the mental health category.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
3 options:3 some evidence
CardiopracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
Open the Cardio pageQigongpracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
A meta-analysis combining randomized and non-randomized human studies found reduced anxiety and depression compared with no treatment or medication, but not compared with TAU. Another meta-analysis reported improvements in depression, anxiety, quality of life, and sleep quality among people with drug addiction.
Open the Qigong pageYogapracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
Open the Yoga page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition3 listedMost likely to help, from the evidence we have
- →PracticesCardioCertaintyMediumSourceRCT
A pooled analysis whose designs were not recorded found reduced drug craving with aerobic exercise (SMD -0.73), HIIT (SMD -2.19), and aerobic+resistance exercise (SMD -1.96). A separate RCT in 58 methadone-treated men reported changes in GPX4, SLC7A11, and ferritin with aerobic exercise, alone or with an NBS supplement.
Who was studied
- People with a condition
Open CardioStudy result
Network meta-analysis of 30 RCTs showing aerobic exercise, HIIT, and aerobic+resistance exercise significantly reduce drug craving versus control (SMD -0.73, -2.19, -1.96 respectively)
- →PracticesQigongCertaintyMediumSourceClinical
A meta-analysis combining randomized and non-randomized human studies found reduced anxiety and depression compared with no treatment or medication, but not compared with TAU. Another meta-analysis reported improvements in depression, anxiety, quality of life, and sleep quality among people with drug addiction.
Who was studied
- People with a condition
- Addiction
- Addiction Drugs
Open QigongStudy result
Meta-analysis of 7 studies (1 RCT, 6 NRS) showing Qigong exercise significantly reduced anxiety and depression compared to no treatment or medication, though not superior to TAU.
- →PracticesYogaCertaintyMediumSourceClinical
In a randomized controlled trial of 59 men with OUD, yoga added to buprenorphine was associated with faster withdrawal stabilization than usual treatment (HR 4.40; median 5 vs 9 days), alongside improvements in HRV measures, anxiety, sleep latency, and pain. A separate trial enrolled 60 people in drug-addiction rehabilitation and proposed yoga as an adjunctive therapy.
Who was studied
- People with a condition
- Addiction
- Addiction Drugs
Open YogaStudy result
RCT of 59 male patients with OUD; yoga add-on to buprenorphine accelerated withdrawal stabilization (HR 4.40; median 5 vs 9 days) and improved HRV (LF/HF, LF, HF power), anxiety (HAM-A), sleep latency, and pain versus treatment as usual
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Drug Addiction worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Drug Addiction is a condition listed in the mental health category. The evidence summarized here considers cocaine craving and relapse among people being treated for CUD. CBD (Cannabidiol) did not reduce either outcome in that setting.
Evidence-backed options
CBD (Cannabidiol) has been investigated in relation to cocaine use disorder, but it did not reduce cocaine craving or relapse among people being treated for CUD. This finding does not support describing CBD as an effective option for these outcomes.
No dose, treatment duration, or timing of effects is specified, so it is not possible to say what was taken, for how long, or how quickly any effect might appear. The health status of the people studied was not specified, which limits how broadly the finding can be applied. Any medical condition should be discussed with a clinician.